Clinical evaluation of suprofen in the treatment of elderly patients with pain of diverse etiology.
This 4-week, open design study was conducted to evaluate the efficacy and safety of suprofen (200-1,200 mg/day) in the treatment of elderly patients with pain of diverse origin, all of whom suffered from secondary disorders. All patients reported pain of moderate to very severe intensity upon study enrollment, which improved considerably in 89% of patients by week 1. 12 of the 16 patients reported good to very good pain reduction by week 4. Suprofen was extremely well tolerated by this patient population, and there were no drug-related study withdrawals. These results show suprofen to be a potentially useful drug for the treatment of elderly patients suffering from various painful conditions.
D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010666:Phenylpropionates / Q000627:therapeutic use*; D013496:Suprofen / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D010666:Phenylpropionates; D013496:Suprofen